High Tower Advisors, LLC Pro Phase Labs, Inc. Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
A detailed history of High Tower Advisors, LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 179,045 shares of PRPH stock, worth $137,864. This represents 0.0% of its overall portfolio holdings.
Number of Shares
179,045
Previous 151,372
18.28%
Holding current value
$137,864
Previous $632,000
31.49%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRPH
# of Institutions
27Shares Held
1.71MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA656KShares$505,0790.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny215KShares$165,6340.0% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$123,7650.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL82.9KShares$63,8570.11% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA64.9KShares$49,9770.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $12.3M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...